Search Within

Andreas Rimner

  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (90)
  2. Journal Article (75)
  3. Editorial (2)
  4. Correspondence (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Department of Medicine (170)
  2. Solid Tumor Oncology Division (170)
  3. Thoracic Oncology (158)
  4. Radiation Oncology, Department of (127)
  5. Surgery (98)
  6. Epidemiology and Biostatistics (68)

More Groups

People
  1. Abraham Wu (87)
  2. Daniel Gomez (73)
  3. Daphna Gelblum (61)
  4. Jamie Chaft (59)
  5. Annemarie Shepherd (57)
  6. Narek Shaverdian (52)

More People

Years
  1. 2025 (1)
  2. 2024 (15)
  3. 2023 (17)
  4. 2022 (26)
  5. 2021 (24)
  6. 2020 (15)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (60)
  2. Journal of Thoracic Oncology (30)
  3. Journal of Clinical Oncology (13)
  4. Radiotherapy and Oncology (9)
  5. Lung Cancer (5)
  6. Advances in Radiation Oncology (4)

More Publications

Publishers
  1. Elsevier Inc. (108)
  2. American Society of Clinical Oncology (19)
  3. Oxford University Press (7)
  4. Elsevier Ireland Ltd. (5)
  5. Elsevier Science, Inc. (4)
  6. American Association for Cancer Research (3)

More Publishers

Results (170)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II randomized trial to evaluate prednisone taper with or without nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z.; Lobaugh, S.; Zhang, Z.; Geyer, A.; Gelblum, D.; Abdulnour, R.; Shepherd, A.; Shaverdian, N.; McCune, M.; Li, H.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • KEYLYNK-013: A phase 3 study of pembrolizumab in combination with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy in patients with newly diagnosed limited-stage SCLC
    Meeting Abstract

    Rimner, A.; Lai, W. V. V.; Califano, R.; Jabbour, S. K.; Faivre-Finn, C.; Cho, B. C.; Kato, T.; Yu, J.; Yu, L.; Zhao, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Improved survival among patients with malignant pleural mesotheliomas who develop immune-related adverse events on immunotherapy
    Meeting Abstract

    Offin, M.; Egger, J. V.; McCarthy, C. G.; Rudneva, V.; Beattie, J.; Ginsberg, M. S.; Sauter, J. L.; Rimner, A.; Rusch, V. W.; Adusumilli, P. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Pre-treatment immune-related markers predict disease outcomes in non-small cell lung cancer patients treated with chemoradiation and durvalumab
    Meeting Abstract

    Thor, M.; Shepherd, A. F.; Apte, A.; Offin, M.; Wu, A. J.; Gelblum, D.; Simone, C. B. 2nd; Rimner, A.; Gomez, D. R.; Deasy, J. O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib vs. concurrent chemoradiation therapy in patients with newly diagnosed limited-stage small-cell lung cancer: KEYLYNK-013
    Meeting Abstract

    Rimner, A.; Lai, V.; Califano, R.; Jabbour, S. K.; Faivre-Finn, C.; Cho, B. C.; Kato, T.; Yu, J.; Yu, L.; Zhao, B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Meeting Abstract

    Hubbeling, H. G.; Choudhury, N.; Falcon, C.; Rusch, V. W.; Park, B.; Ziv, E.; Shaverdian, N.; Gelblum, D.; Shepherd, A. F.; Simone, C. B. 2nd; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • The correlation between changes in cardiac biomarkers and cardiac events in patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT)-exploratory analysis of a phase II study
    Meeting Abstract

    Shepherd, A. F.; Yu, A.; Margaret, C. A.; Rhyne, R. F.; Barnes, G.; Peters, C.; McKnight, D.; Offin, M.; Schmitt, A.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Safety and effectiveness of definitive stereotactic body radiation therapy for early-stage non-small cell lung cancer among older patients: does frailty matter?
    Meeting Abstract

    Smith, D. R.; Riportella, M.; Shepherd, A. F.; Guttmann, D. M.; Shin, J. Y.; Shaverdian, N.; Gelblum, D.; Simone, C. B. 2nd; Gomez, D. R.; Wu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • A Phase III randomized trial of pleurectomy/decortication plus chemotherapy with or without adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) for malignant pleural mesothelioma (MPM) (NRG LU-006)
    Meeting Abstract

    Rimner, A.; Hu, C.; Rusch, V. W.; Gill, R. R.; Simone, C. B. 2nd; Zauderer, M.; Yorke, E. D.; Li, Z.; Peikert, T. D.; Voong, R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Standard vs. higher-dose consolidative thoracic radiation in extensive-stage small cell lung cancer
    Meeting Abstract

    Billing, D.; Rimner, A.; Shepherd, A. F.; Gelblum, D.; Shaverdian, N.; Simone, C. B. 2nd; Lai, V.; Rudin, C. M.; Gomez, D. R.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save